Prof. Lidia Larizza

Universityof Milan, Italy

Email: [email protected]

Qualifications

1968  M.D., Pavia University, Italy

Publications (Selected)

1. Lopez-Atalaya JP, Gervasini C, Mottadelli F, Spena S, Piccione M, Scarano G, Selicorni A, Barco A, Larizza L. Histone acetylation deficits in lymphoblastoid cell lines from patients with Rubinstein-Taybi syndrome. J Med Genet. 2011 Oct 7. [Epub ahead of print]
2. Gervasini C, Mottadelli F, Ciccone R, Castronovo P, Milani D, Scarano G, Bedeschi MF, Belli S, Pilotta A, Selicorni A, Zuffardi O, Larizza L. High frequency of copy number imbalances in Rubinstein-Taybi patients negative to CREBBP mutational analysis.Eur J Hum Genet. 2010 Jul;18(7):768-75
3. Larizza L, Roversi G, Volpi L.Rothmund-Thomson syndromeOrphanet J Rare Dis. 2010 Jan 29;5:2.
4. Volpi L, Roversi G, Colombo EA, Leijsten N, Concolino D, Calabria A, Mencarelli MA, Fimiani M, Macciardi F, Pfundt R, Schoenmakers EF, Larizza L.Targetednext-generation sequencing appoints c16orf57 as clericuzio-type poikiloderma with neutropenia gene.Am J Hum Genet. 2010 Jan;86(1):72-6
5. Bonati MT, Russo S, Finelli P, Valsecchi MR, Cogliati F, Cavalleri F, Roberts W, Elia M, Larizza L.Evaluation of autism traits in Angelman syndrome: a resource to unfold autismgenes.Neurogenetics. 2007 Aug;8(3):169-78. Epub 2007 Apr 6.
6. Lalatta F, Russo S, Gentilin B, Spaccini L, Boschetto C, Cavalleri F, Masciadri M, Gervasini C, Bentivegna A, Castronovo P, Larizza L. Prenatal/neonatal pathology in two cases of Cornelia de Lange syndrome harbouring novel mutations of NIPBL.Genet Med. 2007 Mar;9(3):188-94.
7. Sparago A, Russo S, Cerrato F, Ferraiuolo S, Castorina P, Selicorni A, Schwienbacher C, Negrini M, Battista Ferrero G, Cirillo Silengo M, Anichini C,Larizza L, Riccio A.Mechanisms causing Imprinting Defects in Familial Beckwith-Wiedemann Syndrome with Wilms' Tumour.Hum Mol Genet. 2007, 16(3): 254-264
8. Russo S, Finelli P, Recalcati MP, Ferraiuolo S, Cogliati F, Dalla Bernardina B,Tibiletti MG, Agosti M, Sala M, Bonati MT, Larizza L.Molecular and genomic characterisation of cryptic chromosomal alterations leading to paternal duplication of the 11p15.5 Beckwith-Wiedemann region. J Med Genet. 2006 Aug;43(8):e39.
9. Musio A, Selicorni A, Focarelli ML, Gervasini C, Milani D, Russo S, Vezzoni P, Larizza L. X-linked Cornelia de Lange syndrome owing to SMC1L1 mutations. Nat Genet. 2006 May;38(5):528-30. Epub 2006 Apr 9
10. Cairoli R, Beghini A, Grillo G, Nadali G, Elice F, Ripamonti CB, Colapietro P, Nichelatti M, Pezzetti L, Lunghi M, Cuneo A, Viola A, Ferrara F, Lazzarino M, Rodeghiero F, Pizzolo G, Larizza L, Morra E. Prognostic impact of c-KIT mutations in core binding factor leukemias. An Italian retrospective study. Blood. 2006 May 1;107(9):3463-8. Epub 2005 Dec 29.
11. Roversi G, Pfundt R, Moroni RF, Magnani I, van Reijmersdal S, Pollo B, StraatmanH, Larizza L, Schoenmakers EF. Identification of novel genomic markers related to progression to glioblastoma through genomic profiling of 25 primary glioma cell lines. Oncogene. 2006 Mar 9; 25(10):1571-83.
12. Pierantoni GM, Finelli P,Valtorta E, Giardino D, Rodeschini O, Esposito F, Losa M, Fusco A, Larizza L. High-mobility group A2 gene expression is frequently induced in non-functioning pituitary adenomas (NFPAs), even in the absence of chromosome 12 polysomyEndocr Relat Cancer ; 2005 12: 867-874.
13. Beghini A, Magnani I, Roversi G, Piepoli T, Di Terlizzi S, Moroni RF, Pollo B, Fuhrman Conti AM, Cowell JK, Finocchiaro G, Larizza L. The neural progenitor-restricted isoform of the MARK4 gene in 19q13.2 is upregulated in human gliomas and overexpressed in a subset of glioblastoma cell lines. Oncogene. 2003;22(17):2581-91.
14. Gimelli G, Pujana MA, Patricelli MG, Russo S, Giardino D, Larizza L, Cheung J, Armengol L, Schinzel A, Estivill X, Zuffardi O. Genomic inversions of human chromosome 15q11-q13 in mothers of Angelman syndrome patients with class II (BP2/3) deletions. Hum Mol Genet. 2003; 12(8):849-58.
15. Gervasini C., Bentivegna A., Venturin M., Corrado L., Larizza L., Riva P. Tandem duplication of the NF1 gene detected by high-resolution FISH in the duplicon-rich 17q11.2 region. Hum Genet. 2002 Apr;110(4):314-21
16. Finelli P, Pierantoni GM, Giardino D, Losa M, Rodeschini O, Fedele M, Valtorta E, Mortini P, Croce CM, Larizza L, Fusco A.The high mobility group A2 gene is amplified and overexpressed in human prolactinomas. Cancer Res. 2002, 62(8):2398-405.
17. Beghini A., Tibiletti MG, Roversi G., Chiaravalli AM, Serio G., Capella C., Larizza L Germline mutation in the iuxtamembrane domain of the lit gene in a family with gastrointestinal stromal tumors and urticaria pigmentosa.
18. Cancer, 2001, 92:657-662
19. Beghini A., Ripamonti C.B., Peterlongo P., Roversi G., Cairoli R., Morra E., Larizza L.RNA hyperediting and alternative splicing of hematopoetic cell phosphatase (PTPN6) gene in acute my eloid leukemia. Hum. Mol. Genet, 2000, 9(15): 2297-2304
20. Riva P, Corrado L, Natacci F, Castorina P, Wu BL, Schneider GH, Clementi M, Tenconi R, Korf BR, Larizza L. NF1 microdeletion syndrome: refined FISH characterization of sporadic and familial deletions with locus-specific probes.Am J Hum Genet., 2000, 66(1):100-9